Genetically Engineered Cell Lines: Characterisation and Applications in Toxicity Testing: The Report and Recommendations of ECVAM Workshop 26

Alternatives to Laboratory Animals

Volumn 25, Issue 6, 1997, Pages 625-639

  Wiebel, Friedrich J ^a,b,m   Andersson, Tommy B ^a,c   Casciano, Daniel A ^a,d   Dickins, Maurice ^a,e   Fischer, Volker ^a,f   Glatt, Hansruedi ^a,g   Horbach, Jean ^a,h   Langenbach, Robert J ^a,i   Luyten, Walter ^a,j   Turchi, Gino ^a,k   Vandewalle, Alain ^a,l  

^a ECVAM Europ Ctr Validation A   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c ASTRAZENECA R AND D   (Sweden)

^d Division of Genetic and Reproductive Toxicology   (United States)

^e GLAXOSMITHKLINE   (United Kingdom)

^f NOVARTIS PHARMA AG   (Switzerland)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h UTRECHT UNIVERSITY   (Netherlands)

ⁱ NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^j JANSSEN RESEARCH FOUNDATION   (Belgium)

^k UNIVERSITY OF PISA   (Italy)

^l INSERM   (France)

^m JOINT RESEARCH CENTRE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006908748     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Anon (1994) ECVAM News & Views. ATLA 22, 7-11.
2. Doehmer, J & Greim, H. (1993) Cytochrome P450 in genetically engineered cell cultures: the gene technological approach. In Handbook of Experimental Pharmacology, Volume 105, Cytochrome P450 (ed. J.B Schenkman & H. Greim), pp. 415-429 Berlin, Springer Verlag
3. Waterman, M R & Johnson, E F. (1991) Methods in Enzymology, Vol. 206, Cytrochrome P450, 716 pp. New York: Academic Press
4. Hornhardt, S & Wiebel, F.J (1996) Catalogue of Cell Lines in Toxicology & Pharmacology (GSF Bericht No 3), 249 pp Neuherberg, Germany: GSF.
5. Crespi, CL (1995) Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research Advances in Drug Research 26, 179-235.
6. Sugden, B., Marsh, K & Yates, J (1985) A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus Molecular and Cellular Biology 5, 410-413
7. Doehmer, J , Wolfel, C , Dogra, S, Doehmer, C., Seidel, A. Platt, K.L , Oesch, F & Glatt. H-R. (1992) Applications of stable V79-derived cell lines expressing rat cytochromes P4501A1, 1A2, and 2B1 Xenobiotica 22, 1093-1099.
8. Miller, A D. & Rosman, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-990.
9. Dai, Y., Rashba-Step, J, & Cederbaum, A.I. (1993) Stable expression of human cytochrome P4502E1 in Hep G2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 32, 6928-6937.
10. De Groene, E M , Hassing, I.G.A.M., Blom, M.J., Seinen, W., Fink-Gremmels, J. & Horbach, G.J. (1996). Development of human cytochrome P450 expressing cell lines: application in mutagenicity testing of ochratoxin-A. Cancer Research 56, 299-304.
11. Macé. K , Gonzalez, F.J., McConnell, I.R , Garner, R.C . Avanti, O., Harris, C.C. & Pfeifer, A.M.A. (1994) Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P4501A2. Molecular Carcinogenesis 11, 65-73.
12. Nouso, K., Thorgeisson, S.S. & Battula, N. (1992). Stable expression of human cytochrome P4502E1 in mammalian cells, metabolic activation of nitrosodimethylamine and formation of adducts with cellular DNA. Cancer Research 52, 1796-1800
13. Salompaä, P., Hakkala, J., Pasanen, M., Pelkonen, O , Vahakas, K., Battula, N., Nouso, K. & Raunio, H (1993) Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells. European Journal of Pharmacology 248, 95-102
14. Keown, WA, Campbell, C R. & Kucherlapati, RS (1990) Methods for introducing DNA into mammalian cells Methods in Enzymology 185, 527-537
15. Feigner, J.H., Kumar, R., Sridhar, C N., Wheeler, C J , Tsai, Y.J , Border, R., Ramsey, P , Martin, M & Felgner, P L (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. Journal of Biological Chemistry 269, 2550-2561.
16. Mann, R , Mulligen, R.C. & Baltimore, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus Cell 33, 153-159.
17. Varmus, H.E (1982) Form and function of retroviral proviruses Science 216, 812-820
18. Crespi, C L , Langenbach, R. & Penman, B.W. (1993) Human cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for the expression of cytochromes P450. Toxicology 82, 89-104
19. Barnes, H J , Arlotto, M P & Waterman, M.R. (1991) Expression and enzymatic activity of recombinant cytochrome P450 17α-hydroxylase in Escherichia coli Proceedings of the National Academy of Sciences USA 84, 4073-4077.
20. Renaud, J P , Peyronneau, M.A , Urban, P , Truan, G , Cullin, C , Pompon, D , Beaune, P & Mansuy, D. (1993) Recombinant yeast in drug metabolism. Toxicology 82, 39-52
21. 5 European Journal of Biochemistry 207, 109-116
22. 5. Gene 125, 49-55.
23. Pompon, D., Perret, A., Bellamine, A., Laine, R., Gautier, J.C. & Urban, P. (1995). Genetically engineered yeast cells and their applications. Toxicology Letters 82-83, 815-822.
24. Buters, J.T.M., Korzekwa, K.R., Kunze, K.L., Omata, Y., Hardwick, J.P. & Gonzalez, F.J. (1994). cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metabolism and Disposition 22, 688-692.
25. Summers, M.D. & Smith, G.E. (1987). A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Bulletin No. 1555. Texas, USA: Texas Agriculture Experiment Station
26. Gonzalez, F.J., Kimura, S., Tamura, S. & Gelboin, H.V. (1991). Expression of mammalian cytochrome P450 using baculovirus. Methods in Enzymology 206, 93-99.
27. Lee, C.A., Kadwell, S.H., Kost, T.A. & SerabjitSingh, C.J. (1995). CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. Archives of Biochemistry and Biophysics 319, 157-167.
28. Zuber, M.X., Simpson, E.R. & Waterman, M.R. (1986). Expression of bovine 17α-hydroxylase cytochrome P450 cDNA in non-steroidogenic (COS 1) cells Science 234, 1258-1261.
29. Battula, N., Sagara, J. & Gelboin, H.V. (1987). Expression of P1-450 and P3-450 DNA coding sequences as enzymatically active cytochromes P450 in mammalian cells. Proceedings of the National Academy of Sciences USA 87, 4790-4793.
30. Battula, N. (1989) Transduction of cytochrome P3-450 by retroviruses: constitutive expression of enzymatically active microsomal hemoprotein in animal cells. Journal of Biological Chemistry 264, 2991-2996.
31. Crespi, C.L , Gonzalez, F.J, Steimel, D.T., Turner, R.T., Gelboin, H.V, Penman, B.W & Langenbach, R (1991). A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes. application to mutagenicity testing. Chemical Research in Toxicology 4, 566-572.
32. Crespi, C.L , Penman, B.W, Steimel, D.T, Gelboin, H V & Gonzalez, FJ (1991). The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3 Carcinogenesis 12, 355-359
33. Aoyama, T , Korzekwa, K , Nagata, K., Gillette, J , Gelboin, H V & Gonzalez, F J (1989). cDNA-directed expression of rat testosterone 7α-hydroxylase using the modified Vaccinia virus T7-RNA-polymerase system and evidence for 6α-hydroxylation and D6-testosterone formation European Journal of Biochemistry 181, 331-336.
34. Aovama, T., Yamano, S., Waxman, D.J., Lapenson, D.P., Meyer, U A., Fischer, V., Tyndale, R., Inaba, T , Kalow, W , Gelboin, H.V. & Gonzalez, F.J (1989) Cytochrome P450 hPCN3, a novel cytochrome P4503A gene product that is differentially expressed in adult human liver; cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporin. Journal of Biological Chemistry 264, 10,388-10,395.
35. Wiebel, F.J., Lambiotte, M., Singh, J, Summer, K.H. & Wolff, T. (1984). Expression of carcinogen-metabolising enzymes in continuous cultures of mammalian cells. In Biochemical Basis of Chemical Careinogenesis (ed. H Greim, R. Jung, M. Kramer, H. Marquardt & F. Oesch), pp. 77-88. New York: Raven Press.
36. Kiefer, F. & Wiebel, FJ. (1989) V79 Chinese hamster cells express cytochrome P450 activity after simultaneous exposure to polycyclic aromatic hydrocarbons and aminophyline. Toxicology Letters 48, 265-273.
37. Doehmer, J. & Oesch, F. (1991). V79 Chinese hamster cells genetically engineered for stable expression of cytochrome P450. Methods in Enzymology 206, 117-124.
38. Schneider, A, Schmalix, W.A , Siruguri, V., de Groene, E.M., Horbach, G.J , Kleingeist, B., Lang, D., Böcker, R , Belloc, C., Beaune, P , Greim, H & Doehmer, J (1996). Stable expression of human cytochrome P4503A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 hamster cells. Archives of Biochemistry and Biophysics 332, 295-304.
39. Trinidad, A.C , Wu, R.W, Thompson, L H. & Felton, H.S. (1991). Expression of mouse cytochrome P4501A1 cDNA in repair-deficient and repair-proficient CHO cells Molecular Carcinogenesis 4, 510-518.
40. Kioussis, D. (1992) Oncogenesis and transgenic mice. In Transgenic Mice (ed. F. Grosveld & G. Kollias), pp. 195-210 London Academic Press
41. Lacave, R., Bens, M., Cartier, N., Vallet, V., Robine, S., Pringault. E., Kahn, A. & Vandewalle, A. (1993) Functional properties of proximal tubule cell lines derived from transgenic mice harboring L-pyruvate kinase-SV40 (T) antigen hybrid gene. Journal of Cell Science 104, 705-712.
42. 12 proteins in renal proximal tubule cells. Journal of Biological Chemistry 271, 574-580.
43. Riccaldi, D., Robic, D., Bens, M., Cluzeaud, F., Wu, M.S., Bourbouze, R. & Vandewalle, A (1995). Cultured proximal cells derived from transgenic mouse provide a model to study drug toxicity. Kidney International 48, 722-730
44. Rodrigues, AD. (1994). Use of in vitro human metabolism studies in drug development. An industrial perspective. Biochemical Pharmacology 48, 2147-2156
45. Remmell, R P. & Burchell, B. (1993) Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions. Biochemical Pharmacology 46, 559-566.
46. Glatt, H. (1997). Bioactivation of mutagens via sulfation FASEB Journal 11, 314-321.
47. Glatt, H., Bartsch, L, Christoph. S , Coughtrie, M W.H , Falany, C N , Hagen, M , Landsiedel, R., Pabel, U., Phillips, D.H., Seidel, A, & Yamazoe, Y (1997). Sulfotransferase-mediated activation of mutagens. studied using heterologous expression systems Chemico-Biological Interactions, in press
48. Daly, A K (1996) Molecular basis of polymorphic drug metabolism Journal of Molecular Medicine 11. 539-553